En | De
No articles selected!     View Cart  
You are here: Oncology » Skin 22. June 2024
Advanced search
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Musculoskeletal System
Endocrine System
Gynecologic Neoplasms
Respiratory Tract
Urologic Neoplasms
Respiratory Tract
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 6639  Previews Next
   Articles 1 - 20 / 132762  
Neoadjuvant pembrolizumab, dabrafenib and trametinib in BRAF(V600)-mutant resectable melanoma: the randomized phase 2 NeoTrio trial.
Nat Med
Long GV, Carlino MS, Au-Yeung G, Spillane AJ, Shannon KF, Gyorki DE, Hsiao E, Kapoor R, Thompson JR, Batula I, Howle J, Ch'ng S, Gonzalez M, Saw RPM, Pennington TE, Lo SN, Scolyer RA, Menzies AM.
PMID: 38907159 [PubMed - as supplied by publisher]

Benign tumors and non-melanoma skin cancers in patients with Fanconi anemia.
Fam Cancer
Enache A, Sajjad B, Altintas B, Giri N, McReynolds LJ.
PMID: 38907138 [PubMed - as supplied by publisher]

Sex disparities in melanoma presentation and disease-specific survival in Asian and Pacific Islanders diagnosed with cutaneous melanoma.
Arch Dermatol Res
Taylor MA, Mishra A, Thomas S, Sharma D, Wei EX.
PMID: 38904788 [PubMed - indexed for MEDLINE]

Diagnostic accuracy of high-frequency ultrasound for cutaneous neoplasms: a narrative review of the literature.
Arch Dermatol Res
Hobayan CGP, Gray AN, Waters MF, Mager LA, Kobayashi S, Essien EW, Ulman CA, Kaffenberger BH.
PMID: 38904763 [PubMed - indexed for MEDLINE]

Examining differences in presentation and disease-specific outcomes by race and ethnicity in cutaneous leiomyosarcoma.
Arch Dermatol Res
Taylor MA, Ituarte B, Thomas S, Sharma D, Voss V, Wei EX.
PMID: 38904704 [PubMed - indexed for MEDLINE]

Syringocystadenocarcinoma papilliferum: a systematic review of clinical characteristics, reappraisal of associations, diagnostic pitfalls and management challenges.
Arch Dermatol Res
Wan L, Park A, Khachemoune A.
PMID: 38904691 [PubMed - indexed for MEDLINE]

Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma.
Front Immunol
Matull J, Placke JM, Lodde G, Zaremba A, Utikal J, Terheyden P, Pföhler C, Herbst R, Kreuter A, Welzel J, Kretz J, Möller I, Sucker A, Paschen A, Livingstone E, Zimmer L, Hadaschik E, Ugurel S, Schadendorf D, Thielmann CM, Griewank KG.
PMID: 38903495 [PubMed - indexed for MEDLINE]

Late stage melanoma is hallmarked by low NLGN4X expression leading to HIF1A accumulation.
Br J Cancer
Schörghofer D, Vock L, Mirea MA, Eckel O, Gschwendtner A, Neesen J, Richtig E, Hengstschläger M, Mikula M.
PMID: 38902533 [PubMed - as supplied by publisher]

Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma.
J Clin Oncol
Hamid O, Lewis KD, Weise A, McKean M, Papadopoulos KP, Crown J, Kim TM, Lee DH, Thomas SS, Mehnert J, Kaczmar J, Lakhani NJ, Kim KB, Middleton MR, Rabinowits G, Spira AI, Yushak M, Mehmi I, Fang F, Chen S, Mani J, Jankovic V, Wang F, Fiaschi N, Brennan L, Paccaly A, Masinde S, Salvati M, Fury MG, Kroog G, Lowy I, Gullo G.
PMID: 38900987 [PubMed - as supplied by publisher]

Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.
N Engl J Med
Long GV, Hauschild A, Santinami M, Kirkwood JM, Atkinson V, Mandala M, Merelli B, Sileni VC, Nyakas M, Haydon A, Dutriaux C, Robert C, Mortier L, Schachter J, Schadendorf D, Lesimple T, Plummer R, Larkin J, Tan M, Adnaik SB, Burgess P, Jandoo T, Dummer R.
PMID: 38899716 [PubMed - as supplied by publisher]

Searching for biomarkers to help distinguish Merkel cell carcinoma from cutaneous small cell lung cancer with gene expression analysis.
Skin Res Technol
Bloomstein JD, Doost MS, Meyer SN, Kiuru M, Eisen DB.
PMID: 38898376 [PubMed - indexed for MEDLINE]

Does sex matter? Temporal analyses of melanoma trends among men and women suggest etiologic heterogeneity.
J Invest Dermatol
Olsen CM, Pandeya N, Miranda-Filho A, Rosenberg PS, Whiteman DC.
PMID: 38897542 [PubMed - as supplied by publisher]

A doxycycline-loaded microfiber of poly-metformin/PCL for eradicating melanoma stem cells.
Int J Pharm
Zarei B, Akrami M, Rezaei N, Mahdavi M, Kamankesh M, Haririan I, Asadi M, Navaei-Nigjeh M.
PMID: 38897492 [PubMed - as supplied by publisher]

Genetic causal relationship between gut microbiota and basal cell carcinoma: A two-sample mendelian randomization study.
Skin Res Technol
Luo P, Gao D, Zhang Q.
PMID: 38895789 [PubMed - indexed for MEDLINE]

Intralesional and Infusional Updates for Metastatic Melanoma.
Cancers (Basel)
Dugan MM, Shannon AB, DePalo DK, Perez MC, Zager JS.
PMID: 38893078 [PubMed]

Immune Regulation and Immune Therapy in Melanoma: Review with Emphasis on CD155 Signalling.
Cancers (Basel)
Wu LY, Park SH, Jakobsson H, Shackleton M, Möller A.
PMID: 38893071 [PubMed]

A Narrative Review of the Role of Estrogen (Receptors) in Melanoma.
Int J Mol Sci
Caerts D, Garmyn M, Güvenç C.
PMID: 38892441 [PubMed - indexed for MEDLINE]

Analysis of Oral and Gut Microbiome Composition and Its Impact in Patients with Oral Squamous Cell Carcinoma.
Int J Mol Sci
Matsui K, Tani R, Yamasaki S, Ito N, Hamada A, Shintani T, Otomo T, Tokumaru K, Yanamoto S, Okamoto T.
PMID: 38892262 [PubMed - indexed for MEDLINE]

Melanoma Management: Exploring Staging, Prognosis, and Treatment Innovations.
Int J Mol Sci
Shalata W, Attal ZG, Solomon A, Shalata S, Abu Saleh O, Tourkey L, Abu Salamah F, Alatawneh I, Yakobson A.
PMID: 38891988 [PubMed - indexed for MEDLINE]

Tumor-Infiltrating T Cells in Skin Basal Cell Carcinomas and Squamous Cell Carcinomas: Global Th1 Preponderance with Th17 Enrichment-A Cross-Sectional Study.
Cunha D, Neves M, Silva D, Silvestre AR, Nunes PB, Arrobas F, Ribot JC, Ferreira F, Moita LF, Soares-de-Almeida L, Silva JM, Filipe P, Ferreira J.
PMID: 38891095 [PubMed - indexed for MEDLINE]

   Articles 1 - 20 / 132762    Page 1 of 6639  Previews Next

Rect Bottom
Adserver Footer





Forgot your username or password?


New User? Sign Up

Register to My Medline!


Learn more about the My Medline experience

more >>

  Time frame  

Sky right 1